CD8A and arthritic joint disease: Treatment of C3H mice with anti-CD4-depleting antibody increased arthritis severity and treatment with anti-CD8-depleting antibody decreased arthritis severity, suggesting T cell responses could mediate Lyme disease pathogenesis (30).